Basket | Login | Register

 
 
 
 

ANAVEX®2-73-AD-004 (coming soon)

Phase III trials

Study Information

Name of the study

ANAVEX2-73 for Treatment of Early Alzheimer's Disease

Disease

Early Alzheimer's Disease

Phase

Phase II/III

Information about the drug that will be tested in the studies

Name of the drug

ANAVEX2-73

Where and when will the study be conducted?

European countries involved in the trial (active)

  • The Netherlands
  • UK

Information for your doctor

Clinicaltrials.gov identifier

NCT03790709

Link to full text

https://clinicaltrials.gov/ct2/show/NCT03790709

 

 
 

Last Updated: Tuesday 10 November 2020

 

 
 

Options